Francesca Colombo

Segrate, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications

The clinical usefulness of knowing CHRNA5 polymorphism genotype: paving the way for personalized therapy.

The clinical usefulness of knowing CHRNA5 polymorphism genotype: paving the way for personalized therapy.

Journal: Tumori
Published: March 11, 2026

Longitudinal Whole-Exome Sequencing of Cell-Free DNA Reveals Molecular Evolution and Heterogeneous Clinical Outcomes in PD-L1 Stratified Advanced NSCLC Adenocarcinoma Patients Treated with Atezolizumab.

Longitudinal Whole-Exome Sequencing of Cell-Free DNA Reveals Molecular Evolution and Heterogeneous Clinical Outcomes in PD-L1 Stratified Advanced NSCLC Adenocarcinoma Patients Treated with Atezolizumab.

Journal: International journal of molecular sciences
Published: February 24, 2026

Financial capacity in patients with brain tumors: determinants and evolution after neurosurgery.

Financial capacity in patients with brain tumors: determinants and evolution after neurosurgery.

Journal: Frontiers in neurology
Published: December 23, 2025

Correction: PFOA biomonitoring and kidney cancer risk: a meta-analysis of serum levels.

Correction: PFOA biomonitoring and kidney cancer risk: a meta-analysis of serum levels.

Journal: Frontiers in oncology
Published: September 15, 2025

Regulatory polymorphisms of MSH6, MSH2, FBXO11, and PPP1R21 genes affect survival of patients with immunotherapy-treated lung cancer.

Regulatory polymorphisms of MSH6, MSH2, FBXO11, and PPP1R21 genes affect survival of patients with immunotherapy-treated lung cancer.

Journal: Journal for immunotherapy of cancer
Published: August 04, 2025

PFOA biomonitoring and kidney cancer risk: a meta-analysis of serum levels.

PFOA biomonitoring and kidney cancer risk: a meta-analysis of serum levels.

Journal: Frontiers in oncology
Published: March 15, 2025

Harnessing Baseline Radiomic Features in Early-Stage NSCLC: What Role in Clinical Outcome Modeling for SBRT Candidates?

Harnessing Baseline Radiomic Features in Early-Stage NSCLC: What Role in Clinical Outcome Modeling for SBRT Candidates?

Journal: Cancers
Published: January 08, 2025

Germline Whole-Exome Sequencing in Non-Smoker Lung Cancer Patients Reveals Pathogenic Variants in Lung Cancer Driver Genes.

Germline Whole-Exome Sequencing in Non-Smoker Lung Cancer Patients Reveals Pathogenic Variants in Lung Cancer Driver Genes.

Journal: Genes, chromosomes & cancer
Published: December 23, 2024

Proton therapy for pediatric malignancies: Indications and challenges focusing on the oncological landscape.

Proton therapy for pediatric malignancies: Indications and challenges focusing on the oncological landscape.

Journal: Tumori
Published: October 16, 2024

Unsupervised Deep Learning for Synthetic CT Generation from CBCT Images for Proton and Carbon Ion Therapy for Paediatric Patients.

Unsupervised Deep Learning for Synthetic CT Generation from CBCT Images for Proton and Carbon Ion Therapy for Paediatric Patients.

Journal: Sensors (Basel, Switzerland)
Published: September 23, 2024

Germline Polymorphisms Associated with Overall Survival in Lung Adenocarcinoma: Genome-Wide Analysis.

Germline Polymorphisms Associated with Overall Survival in Lung Adenocarcinoma: Genome-Wide Analysis.

Journal: Cancers
Published: August 19, 2024

A genome-wide association study of European advanced cancer patients treated with opioids identifies regulatory variants on chromosome 20 associated with pain intensity.

A genome-wide association study of European advanced cancer patients treated with opioids identifies regulatory variants on chromosome 20 associated with pain intensity.

Journal: European journal of pain (London, England)
Published: August 06, 2024
Showing 1-12 of 60

Last Updated: 09/26/2026